1.800.979.8292
Miraca Life Sciences News
Please check this page often for the latest news and updates from
Dr. Frank Basile Joins Miraca Life Sciences as President and Chief Executive Officer
Experienced Healthcare Veteran to Implement New Growth Strategy Dallas, TX, May 1, 2012 – Miraca Life Sciences, Inc. (“MLS”), a specialist in the development and commercialization of the highest quality anatomic pathology services, today announced that Dr. Frank Basile will …
Caris Diagnostics Announces Name Change to Miraca Life Sciences
Company to Provide Same High-Quality Anatomic Pathology Services Under New Name Tokyo, Japan & Irving, Texas, February 3, 2012 – Caris Diagnostics, specializing in academic-caliber anatomic pathology services, today announced a company name change to Miraca Life Sciences, Inc., following …
Caris Life Sciences and Miraca Holdings Complete Sale of Anatomic Pathology Business
Tokyo, Japan & Irving, Texas – November 22, 2011 – Miraca Holdings Inc. (“Miraca”), Japan’s largest clinical diagnostics and laboratory testing service provider, and Caris Life Sciences, Inc. (“CLS”), a privately-held company headquartered in Texas specializing in the development and …
Caris Diagnostics Presents Research at 2011 Annual Meeting of the American College of Gastroenterology
Company’s Research Efforts Include 15 Poster Presentations; Strong Presence in Key Areas of Colorectal Research IRVING, Texas, October 31, 2011 — Caris Diagnostics, a leading provider of expert anatomic pathology services, announced today upcoming highlights from the Company’s presentations at …
Olympus America Inc. and Caris Diagnostics Partner to Unveil New Pathology Reporting Tool
Preferred partnership automates pathology for endoscopy providers, thereby enhancing diagnostic patient care. Center Valley, PA and Irving, TX, October 28, 2011 — Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other …
Miraca Holdings to Acquire Caris Life Sciences’ Anatomic Pathology Business
Tokyo, Japan & Irving, Texas – October 6, 2011 – Miraca Holdings Inc. (“Miraca”), Japan’s largest clinical diagnostics and laboratory testing service provider, and Caris Life Sciences, Inc. (“CLS”), a privately-held company headquartered in Texas and specializing in the development …
Caris Life Sciences Presents Research Findings at Digestive Disease Week
Data Presented in Two Podium Presentations and Five Posters Demonstrate Quality and Depth of Carispath™ Gastrointestinal (GI) Pathology Services IRVING, TX, May 10, 2011 — Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare …
Caris Life Sciences Reports 2010 Highlights
Leading Biosciences Company’s 2010 Performance Characterized by Cutting-Edge Technology Advancements and Significant Growth IRVING, TX, January 18, 2011 — Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest-quality anatomic pathology, molecular …
Signal Genetics and Caris Life Sciences Announce Commercialization Partnership for New Myeloma Gene Expression Test
NEW YORK, NY, and IRVING, Texas – January 5, 2011 – Signal Genetics, the parent company of Myeloma Health LLC, a privately held predictive genetic testing company focused on oncology, and Caris Life Sciences, Inc., a leading biosciences company focused …
Caris Life Sciences Presents Key Findings Related to Plasma Cell Disorders
Dr. Raul Braylan to present clinical utility data on flow cytometric analysis for patients with plasma cell disorders at the 2010 American Society of Hematology annual meeting IRVING, Texas – December 3, 2010 – Caris Life Sciences, Inc., a leading …
About Us
© 2012
Trademarks are the property of their respective owners.